HeraMED Limited announced that Mr. David Groberman has resigned as Chief Executive Officer with immediate effect. David will continue in a non-Executive role, as Product Strategist, delivering advice and strategic input on the evolution of the technology. Dr Ron Weinberger will continue as Executive Chairman, leading the commercialisation of HeraCARE until a permanent Managing Director and CEO is found.

A search will commence at the appropriate time and further announcements will be made at the appropriate time.